RNA疫苗-话题@MedSci

#RNA疫苗#

127篇内容 | 3100人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1947411, encodeId=1e9c194e411ab, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=JAMA Network Open：已经感染过新冠的人应该怎么办？研究显示，1剂mRNA疫苗就够了, objectType=article, longId=215828, objectId=c4c52158289c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4c52158289c, replyNumber=0, likeNumber=70, createdTime=2022-02-23, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4c52158289c, moduleTitle=JAMA Network Open：已经感染过新冠的人应该怎么办？研究显示，1剂mRNA疫苗就够了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4c52158289c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947389, encodeId=ebc1194e389ba, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, objectType=article, longId=212051, objectId=95b6212051bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b6212051bf, replyNumber=0, likeNumber=96, createdTime=2021-06-11, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b6212051bf, moduleTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95b6212051bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947375, encodeId=6c66194e375f2, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性, objectType=article, longId=208472, objectId=4e562084e27e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e562084e27e, replyNumber=0, likeNumber=94, createdTime=2021-10-13, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e562084e27e, moduleTitle=JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e562084e27e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947376, encodeId=9189194e37686, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=BMJ：辉瑞疫苗文献遭泄露，mRNA疫苗再受质疑, objectType=article, longId=208495, objectId=aa8220849555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa8220849555, replyNumber=0, likeNumber=57, createdTime=2021-12-29, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa8220849555, moduleTitle=BMJ：辉瑞疫苗文献遭泄露，mRNA疫苗再受质疑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa8220849555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947374, encodeId=3373194e3745e, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=JAMA：接种COVID-19 mRNA疫苗后的急性过敏反应发生率, objectType=article, longId=208217, objectId=251b20821e53, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=251b20821e53, replyNumber=0, likeNumber=59, createdTime=2022-02-08, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=251b20821e53, moduleTitle=JAMA：接种COVID-19 mRNA疫苗后的急性过敏反应发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=251b20821e53)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947408, encodeId=317f194e4089b, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=疫苗混打更有效？丹麦研究：混打AZ和mRNA疫苗防护力提升至88%, objectType=article, longId=215398, objectId=69a021539877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a021539877, replyNumber=0, likeNumber=51, createdTime=2021-12-18, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a021539877, moduleTitle=疫苗混打更有效？丹麦研究：混打AZ和mRNA疫苗防护力提升至88%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a021539877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947383, encodeId=7e59194e3839f, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=柳叶刀：BNT162b2 mRNA疫苗对B1.1.7变异株有效，但仍需加强预防, objectType=article, longId=210498, objectId=47692104986c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47692104986c, replyNumber=0, likeNumber=88, createdTime=2021-06-28, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47692104986c, moduleTitle=柳叶刀：BNT162b2 mRNA疫苗对B1.1.7变异株有效，但仍需加强预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47692104986c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947386, encodeId=e426194e38633, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=美国将放弃新冠病毒疫苗的知识产权专利，可能有助于mRNA疫苗的普及, objectType=article, longId=210880, objectId=87ba2108806a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87ba2108806a, replyNumber=0, likeNumber=60, createdTime=2022-03-21, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87ba2108806a, moduleTitle=美国将放弃新冠病毒疫苗的知识产权专利，可能有助于mRNA疫苗的普及, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87ba2108806a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947371, encodeId=9a30194e37178, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2021年1月19日全球新冠肺炎（COVID-19）疫情简报，确诊超9596万，辉瑞和Moderna疫苗在多国出现严重不良反应, objectType=article, longId=205884, objectId=7afb20588457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7afb20588457, replyNumber=0, likeNumber=83, createdTime=2021-01-27, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7afb20588457, moduleTitle=2021年1月19日全球新冠肺炎（COVID-19）疫情简报，确诊超9596万，辉瑞和Moderna疫苗在多国出现严重不良反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7afb20588457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947368, encodeId=e2b4194e368a9, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, objectType=article, longId=204415, objectId=8ae32044156a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae32044156a, replyNumber=0, likeNumber=71, createdTime=2021-02-09, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae32044156a, moduleTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae32044156a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947367, encodeId=9fbe194e367db, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：mRNA疫苗mRNA-1273用于新冠肺炎的预防研究, objectType=article, longId=203322, objectId=c1d2203322a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1d2203322a9, replyNumber=0, likeNumber=90, createdTime=2021-01-07, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1d2203322a9, moduleTitle=NEJM：mRNA疫苗mRNA-1273用于新冠肺炎的预防研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1d2203322a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947373, encodeId=f0fc194e3730b, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：BNT162b2 mRNA疫苗在以色列大规模接种后的有效性评估, objectType=article, longId=207615, objectId=2f9f20e615fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f9f20e615fe, replyNumber=0, likeNumber=93, createdTime=2021-03-19, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f9f20e615fe, moduleTitle=NEJM：BNT162b2 mRNA疫苗在以色列大规模接种后的有效性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f9f20e615fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947398, encodeId=6feb194e39813, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=J Control Release：mRNA疫苗迎来黎明，我们准备好了吗？, objectType=article, longId=213373, objectId=4b792133e32f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b792133e32f, replyNumber=0, likeNumber=73, createdTime=2022-03-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b792133e32f, moduleTitle=J Control Release：mRNA疫苗迎来黎明，我们准备好了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b792133e32f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947370, encodeId=a2f1194e370fc, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=重磅! 使用过破尿酸美容人群或许不合适接种Moderna疫苗，恐引发严重过敏反应, objectType=article, longId=204936, objectId=b2352049367b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2352049367b, replyNumber=0, likeNumber=65, createdTime=2021-03-01, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2352049367b, moduleTitle=重磅! 使用过破尿酸美容人群或许不合适接种Moderna疫苗，恐引发严重过敏反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2352049367b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947390, encodeId=24cd194e39055, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论, objectType=article, longId=212205, objectId=55fd212205a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fd212205a6, replyNumber=0, likeNumber=67, createdTime=2022-01-05, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fd212205a6, moduleTitle=BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fd212205a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947377, encodeId=aa8b194e37793, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=美国疾控真实世界研究：单剂辉瑞与Moderna疫苗有效率为80%, objectType=article, longId=209217, objectId=008920921e2e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=008920921e2e, replyNumber=0, likeNumber=78, createdTime=2021-05-21, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=008920921e2e, moduleTitle=美国疾控真实世界研究：单剂辉瑞与Moderna疫苗有效率为80%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=008920921e2e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947372, encodeId=a927194e372b1, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=mRNA疫苗不只是预防新冠，未来会开辟mRNA时代，三位诺奖得主点评mRNA疫苗, objectType=article, longId=206981, objectId=f697206981cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f697206981cd, replyNumber=0, likeNumber=66, createdTime=2021-11-17, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f697206981cd, moduleTitle=mRNA疫苗不只是预防新冠，未来会开辟mRNA时代，三位诺奖得主点评mRNA疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f697206981cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947363, encodeId=ced1194e36321, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体, objectType=article, longId=194442, objectId=298e1944429a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298e1944429a, replyNumber=0, likeNumber=52, createdTime=2020-07-19, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298e1944429a, moduleTitle=重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298e1944429a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947369, encodeId=d014194e36973, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2020年12月18日全球新冠肺炎（COVID-19）疫情简报，确诊超7520万，Moderna疫苗也被FDA批准上市, objectType=article, longId=204644, objectId=2780204644ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2780204644ec, replyNumber=0, likeNumber=53, createdTime=2021-10-04, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2780204644ec, moduleTitle=2020年12月18日全球新冠肺炎（COVID-19）疫情简报，确诊超7520万，Moderna疫苗也被FDA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2780204644ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947359, encodeId=fae5194e35950, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nature：新冠mRNA疫苗I期临床试验在美国开展, objectType=article, longId=190285, objectId=6b37190285b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b37190285b3, replyNumber=0, likeNumber=67, createdTime=2020-10-18, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b37190285b3, moduleTitle=Nature：新冠mRNA疫苗I期临床试验在美国开展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b37190285b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RNA疫苗

2020-05-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

JAMA Network Open：已经感染过新冠的人应该怎么办？研究显示，1剂mRNA疫苗就够了

2022-02-23

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗

2021-06-11

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性

2021-10-13

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

BMJ：辉瑞疫苗文献遭泄露，mRNA疫苗再受质疑

2021-12-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

JAMA：接种COVID-19 mRNA疫苗后的急性过敏反应发生率

2022-02-08

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

疫苗混打更有效？丹麦研究：混打AZ和mRNA疫苗防护力提升至88%

2021-12-18

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

柳叶刀：BNT162b2 mRNA疫苗对B1.1.7变异株有效，但仍需加强预防

2021-06-28

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

美国将放弃新冠病毒疫苗的知识产权专利，可能有助于mRNA疫苗的普及

2022-03-21

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2021年1月19日全球新冠肺炎（COVID-19）疫情简报，确诊超9596万，辉瑞和Moderna疫苗在多国出现严重不良反应

2021-01-27

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权

2021-02-09

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：mRNA疫苗mRNA-1273用于新冠肺炎的预防研究

2021-01-07

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：BNT162b2 mRNA疫苗在以色列大规模接种后的有效性评估

2021-03-19

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

J Control Release：mRNA疫苗迎来黎明，我们准备好了吗？

2022-03-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

重磅! 使用过破尿酸美容人群或许不合适接种Moderna疫苗，恐引发严重过敏反应

2021-03-01

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论

2022-01-05

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

美国疾控真实世界研究：单剂辉瑞与Moderna疫苗有效率为80%

2021-05-21

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

mRNA疫苗不只是预防新冠，未来会开辟mRNA时代，三位诺奖得主点评mRNA疫苗

2021-11-17

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

重磅！Moderna的mRNA疫苗可激发健康志愿者产生SARS-CoV-2抗体

2020-07-19

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2020年12月18日全球新冠肺炎（COVID-19）疫情简报，确诊超7520万，Moderna疫苗也被FDA批准上市

2021-10-04

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nature：新冠mRNA疫苗I期临床试验在美国开展

2020-10-18

科室
- - 订阅+
  - 更多科室
工具
服务